original articlesmelanomaRandomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma
melanoma
Under an Elsevier user license
open archive
Key words
melanoma
metastasis
poly ADP-ribose polymerase inhibitor
Cited by (0)
Copyright © 2015 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.